Skip to Main Content

Advertisement

Skip Nav Destination

M200 (volociximab), a chimeric antibody against integrin alpha5 beta1, inhibits tumor growth by multiple mechanisms

Cancer Res (2005) 65 (9_Supplement): 1063.
Currently there are no citedby results. Try again later.
Close Modal

or Create an Account

Close Modal
Close Modal